Arrowstreet Capital’s Aveanna Healthcare AVAH Stock Holding History

Arrowstreet Capital’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.3M	Buy	1,672,672 +861,417	+106%	+$6.07M	0.01%	970
2026 Q1	$5.22M	Sell	811,255 -509,355	-39%	-$3.94M	﹤0.01%	1147
2025 Q4	$10.8M	Buy	1,320,610 +361,122	+38%	+$3.26M	0.01%	903
2025 Q3	$8.51M	Buy	959,488 +785,452	+451%	+$4.97M	0.01%	1007
2025 Q2	$910K	Sell	174,036 -5,541	-3%	-$28.2K	﹤0.01%	1635
2025 Q1	$973K	Sell	179,577 -103,299	-37%	-$487K	﹤0.01%	1476
2024 Q4	$1.29M	Buy	282,876 +37,801	+15%	+$194K	﹤0.01%	1391
2024 Q3	$1.27M	Buy	+245,075	New	+$1.11M	﹤0.01%	1324

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital's AVAH Position: Q2 2026 in Review

Arrowstreet Capital increased its Aveanna Healthcare (AVAH) stake by 106% in Q2 2026, buying an estimated $6.07M and bringing the position to 1,672,672 shares worth $14.3M. The position accounts for 0.01% of the portfolio, ranked #970.

Arrowstreet Capital first reported a position in AVAH in Q3 2024 and has held it in 8 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

Arrowstreet Capital held 1,672,672 shares of Aveanna Healthcare worth $14.3M as of Q2 2026.
Arrowstreet Capital bought 861,417 Aveanna Healthcare shares in Q2 2026, an estimated $6.07M.
Aveanna Healthcare made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #970 holding.
Arrowstreet Capital first reported a position in Aveanna Healthcare in Q3 2024 and has held it in 8 quarters since.
215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.